Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $661.36 million. The enterprise value is $438.69 million.
| Market Cap | 661.36M |
| Enterprise Value | 438.69M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 19.55 million shares outstanding. The number of shares has increased by 14.76% in one year.
| Current Share Class | 19.55M |
| Shares Outstanding | 19.55M |
| Shares Change (YoY) | +14.76% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 32.91% |
| Owned by Institutions (%) | 68.68% |
| Float | 11.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.29, with a Debt / Equity ratio of 0.02.
| Current Ratio | 22.29 |
| Quick Ratio | 21.90 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,373.13 |
Financial Efficiency
Return on equity (ROE) is -33.80% and return on invested capital (ROIC) is -23.09%.
| Return on Equity (ROE) | -33.80% |
| Return on Assets (ROA) | -22.29% |
| Return on Invested Capital (ROIC) | -23.09% |
| Return on Capital Employed (ROCE) | -41.88% |
| Weighted Average Cost of Capital (WACC) | 5.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.43M |
| Employee Count | 60 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TECX has paid $331,000 in taxes.
| Income Tax | 331,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.04% in the last 52 weeks. The beta is 0.22, so TECX's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +58.04% |
| 50-Day Moving Average | 31.59 |
| 200-Day Moving Average | 26.14 |
| Relative Strength Index (RSI) | 59.37 |
| Average Volume (20 Days) | 180,293 |
Short Selling Information
The latest short interest is 1.76 million, so 9.03% of the outstanding shares have been sold short.
| Short Interest | 1.76M |
| Short Previous Month | 1.94M |
| Short % of Shares Out | 9.03% |
| Short % of Float | 14.82% |
| Short Ratio (days to cover) | 8.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -94.93M |
| Pretax Income | -85.46M |
| Net Income | -85.79M |
| EBITDA | -93.66M |
| EBIT | -94.93M |
| Earnings Per Share (EPS) | -$4.56 |
Balance Sheet
The company has $227.07 million in cash and $4.40 million in debt, with a net cash position of $222.67 million or $11.39 per share.
| Cash & Cash Equivalents | 227.07M |
| Total Debt | 4.40M |
| Net Cash | 222.67M |
| Net Cash Per Share | $11.39 |
| Equity (Book Value) | 223.85M |
| Book Value Per Share | 11.64 |
| Working Capital | 220.73M |
Cash Flow
In the last 12 months, operating cash flow was -$72.14 million and capital expenditures -$279,000, giving a free cash flow of -$72.42 million.
| Operating Cash Flow | -72.14M |
| Capital Expenditures | -279,000 |
| Depreciation & Amortization | 1.26M |
| Net Borrowing | -451,000 |
| Free Cash Flow | -72.42M |
| FCF Per Share | -$3.70 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TECX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.76% |
| Shareholder Yield | -14.76% |
| Earnings Yield | -12.57% |
| FCF Yield | -10.61% |
Analyst Forecast
The average price target for TECX is $77.56, which is 129.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $77.56 |
| Price Target Difference | 129.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |